Browsing by Author Forsyth, Cecily

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 5 of 5
Issue DateTitleAuthor(s)Citation
2017Busulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyureaStevenson, William; Bennett, Michael; Douglas, Genevieve; Forsyth, Cecily; Grigg, Andrew; Harrison, Claire; Hounsell, John; Ratnasingam, Sumita; Ritchie, D; Ross, David M; Northern Clinical School: MedicineBusulfan is effective second-line therapy for older patients with Philadelphia-negative myeloproliferative neoplasms intolerant of or unresponsive to hydroxyurea, Leukemia and Lymphoma, vol.58, 1, 2017,pp 89-95
2017A case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosisHo, Joy Phoebe; Bajel, A; Burbury, Kate; Dunlop, L; Durrant, S; Forsyth, Cecily; Perkins, A; Ross, David M; Central Clinical School: MedicineA case-based discussion of clinical problems in the management of patients treated with ruxolitinib for myelofibrosis, Internal Medicine Journal, vol.47, 3, 2017,pp 262-268
2012The Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory diseaseChe, Yiping; Christopherson, Richard; Mulligan, Stephen; Best, Giles; Forsyth, Cecily; Singh, Nisha; Molecular Bioscience; Molecular Bioscience; Northern Clinical School: MedicineThe Hsp90 inhibitor SNX-7081 synergizes with and restores sensitivity to fludarabine in chronic lymphocytic leukemia cells with lesions in the TP53 pathway: a potential treatment strategy for fludarabine refractory disease, Leukemia and Lymphoma, vol.53, 7, 2012,pp 1367-1375
2013Immunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemiaBest, Giles; Crassini, Kyle; Freeman, Jane; MacKinlay, N; Mulligan, Stephen; Stevenson, William; Forsyth, Cecily; Han, Ping; Northern Clinical School: Medicine; Northern Clinical School: Kolling Institute; School of Medical Sciences: Anatomy & Histology; Northern Clinical School: Medicine; Northern Clinical School: Medicine; Northern Clinical School: MedicineImmunoglobulin G subclass deficiency and infection risk in 150 patients with chronic lymphocytic leukemia, Leukemia and Lymphoma, vol.54, 1, 2013,pp 99-104
2011Positron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants.Estell, Jane; Fulham, Michael; Trotman, Judith; Decaudin, Didier; et al, various; Fabiani, Bettina; Forsyth, Cecily; Fournier, Marion; Gabarre, Jean; Gyan, Emmanuel; Janíkova, Andrea; Lamy, Thierry; Salles, Bruno; Seymour, John Francis; Shpilberg, Ofer; Sonet, Anne; Tilly, Hervé; Concord Clinical School: Medicine; Central Clinical School: Medicine; Concord Clinical School: MedicinePositron Emission Tomography-Computed Tomography (PET-CT) After Induction Therapy Is Highly Predictive of Patient Outcome in Follicular Lymphoma: Analysis of PET-CT in a Subset of PRIMA Trial Participants., Journal of Clinical Oncology, vol.29, 23, 2011,pp 3194-3200